Logo image of CPAY

CORPAY INC (CPAY) Stock Fundamental Analysis

NYSE:CPAY - New York Stock Exchange, Inc. - US2199481068 - Common Stock

373.41  -2.2 (-0.59%)

After market: 373.41 0 (0%)

Fundamental Rating

6

Overall CPAY gets a fundamental rating of 6 out of 10. We evaluated CPAY against 101 industry peers in the Financial Services industry. CPAY has an excellent profitability rating, but there are some minor concerns on its financial health. CPAY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CPAY had positive earnings in the past year.
CPAY had a positive operating cash flow in the past year.
CPAY had positive earnings in each of the past 5 years.
CPAY had a positive operating cash flow in each of the past 5 years.
CPAY Yearly Net Income VS EBIT VS OCF VS FCFCPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

1.2 Ratios

CPAY has a better Return On Assets (5.75%) than 81.19% of its industry peers.
With an excellent Return On Equity value of 32.83%, CPAY belongs to the best of the industry, outperforming 93.07% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.10%, CPAY belongs to the top of the industry, outperforming 88.12% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CPAY is above the industry average of 7.84%.
Industry RankSector Rank
ROA 5.75%
ROE 32.83%
ROIC 12.1%
ROA(3y)6.46%
ROA(5y)6.6%
ROE(3y)32.25%
ROE(5y)28.37%
ROIC(3y)12.39%
ROIC(5y)11.79%
CPAY Yearly ROA, ROE, ROICCPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

The Profit Margin of CPAY (26.14%) is better than 80.20% of its industry peers.
In the last couple of years the Profit Margin of CPAY has declined.
Looking at the Operating Margin, with a value of 44.43%, CPAY belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
In the last couple of years the Operating Margin of CPAY has remained more or less at the same level.
With an excellent Gross Margin value of 78.29%, CPAY belongs to the best of the industry, outperforming 86.14% of the companies in the same industry.
In the last couple of years the Gross Margin of CPAY has declined.
Industry RankSector Rank
OM 44.43%
PM (TTM) 26.14%
GM 78.29%
OM growth 3Y2.7%
OM growth 5Y-0.33%
PM growth 3Y-3.94%
PM growth 5Y-4.76%
GM growth 3YN/A
GM growth 5Y-4.8%
CPAY Yearly Profit, Operating, Gross MarginsCPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

5

2. Health

2.1 Basic Checks

CPAY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CPAY has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CPAY has less shares outstanding
The debt/assets ratio for CPAY has been reduced compared to a year ago.
CPAY Yearly Shares OutstandingCPAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
CPAY Yearly Total Debt VS Total AssetsCPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

CPAY has an Altman-Z score of 2.36. This is not the best score and indicates that CPAY is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CPAY (2.36) is better than 79.21% of its industry peers.
The Debt to FCF ratio of CPAY is 3.34, which is a good value as it means it would take CPAY, 3.34 years of fcf income to pay off all of its debts.
CPAY's Debt to FCF ratio of 3.34 is fine compared to the rest of the industry. CPAY outperforms 69.31% of its industry peers.
A Debt/Equity ratio of 2.13 is on the high side and indicates that CPAY has dependencies on debt financing.
With a Debt to Equity ratio value of 2.13, CPAY is not doing good in the industry: 65.35% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 3.34
Altman-Z 2.36
ROIC/WACC1.46
WACC8.3%
CPAY Yearly LT Debt VS Equity VS FCFCPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.3 Liquidity

CPAY has a Current Ratio of 1.05. This is a normal value and indicates that CPAY is financially healthy and should not expect problems in meeting its short term obligations.
CPAY has a Current ratio of 1.05. This is comparable to the rest of the industry: CPAY outperforms 49.51% of its industry peers.
CPAY has a Quick Ratio of 1.05. This is a normal value and indicates that CPAY is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.05, CPAY perfoms like the industry average, outperforming 53.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
CPAY Yearly Current Assets VS Current LiabilitesCPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

6

3. Growth

3.1 Past

CPAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.50%, which is quite good.
CPAY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.95% yearly.
The Revenue has been growing slightly by 4.68% in the past year.
CPAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.08% yearly.
EPS 1Y (TTM)9.5%
EPS 3Y15.12%
EPS 5Y9.95%
EPS Q2Q%11.36%
Revenue 1Y (TTM)4.68%
Revenue growth 3Y16.3%
Revenue growth 5Y9.08%
Sales Q2Q%6.01%

3.2 Future

CPAY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.24% yearly.
CPAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.94% yearly.
EPS Next Y14.56%
EPS Next 2Y15.53%
EPS Next 3Y16.16%
EPS Next 5Y16.24%
Revenue Next Year5.41%
Revenue Next 2Y8.53%
Revenue Next 3Y9.02%
Revenue Next 5Y8.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CPAY Yearly Revenue VS EstimatesCPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
CPAY Yearly EPS VS EstimatesCPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.64, CPAY is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of CPAY is on the same level as its industry peers.
CPAY's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.19.
With a Price/Forward Earnings ratio of 16.53, CPAY is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CPAY is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.37, CPAY is valued a bit cheaper.
Industry RankSector Rank
PE 20.64
Fwd PE 16.53
CPAY Price Earnings VS Forward Price EarningsCPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CPAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CPAY is cheaper than 61.39% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CPAY is valued a bit cheaper than 78.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.21
EV/EBITDA 15.17
CPAY Per share dataCPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

CPAY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CPAY may justify a higher PE ratio.
A more expensive valuation may be justified as CPAY's earnings are expected to grow with 16.16% in the coming years.
PEG (NY)1.42
PEG (5Y)2.07
EPS Next 2Y15.53%
EPS Next 3Y16.16%

0

5. Dividend

5.1 Amount

No dividends for CPAY!.
Industry RankSector Rank
Dividend Yield N/A

CORPAY INC

NYSE:CPAY (1/22/2025, 8:15:48 PM)

After market: 373.41 0 (0%)

373.41

-2.2 (-0.59%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners96.96%
Inst Owner Change-0.1%
Ins Owners3.09%
Ins Owner Change5.56%
Market Cap26.03B
Analysts80
Price Target407.62 (9.16%)
Short Float %1.78%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.25%
Min EPS beat(2)-1.45%
Max EPS beat(2)-1.06%
EPS beat(4)0
Avg EPS beat(4)-1.77%
Min EPS beat(4)-2.8%
Max EPS beat(4)-1.06%
EPS beat(8)2
Avg EPS beat(8)-1.13%
EPS beat(12)5
Avg EPS beat(12)0%
EPS beat(16)8
Avg EPS beat(16)0.65%
Revenue beat(2)0
Avg Revenue beat(2)-1.76%
Min Revenue beat(2)-1.82%
Max Revenue beat(2)-1.7%
Revenue beat(4)0
Avg Revenue beat(4)-2.76%
Min Revenue beat(4)-5.28%
Max Revenue beat(4)-1.7%
Revenue beat(8)1
Avg Revenue beat(8)-2.01%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)7
Avg Revenue beat(16)-0.49%
PT rev (1m)1.03%
PT rev (3m)22.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.25%
EPS NY rev (1m)0%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 20.64
Fwd PE 16.53
P/S 6.71
P/FCF 11.21
P/OCF 10.46
P/B 8.43
P/tB N/A
EV/EBITDA 15.17
EPS(TTM)18.09
EY4.84%
EPS(NY)22.58
Fwd EY6.05%
FCF(TTM)33.3
FCFY8.92%
OCF(TTM)35.71
OCFY9.56%
SpS55.62
BVpS44.29
TBVpS-71.63
PEG (NY)1.42
PEG (5Y)2.07
Profitability
Industry RankSector Rank
ROA 5.75%
ROE 32.83%
ROCE 18.55%
ROIC 12.1%
ROICexc 13.79%
ROICexgc 105.25%
OM 44.43%
PM (TTM) 26.14%
GM 78.29%
FCFM 59.87%
ROA(3y)6.46%
ROA(5y)6.6%
ROE(3y)32.25%
ROE(5y)28.37%
ROIC(3y)12.39%
ROIC(5y)11.79%
ROICexc(3y)14.91%
ROICexc(5y)14.06%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.48%
ROCE(5y)16.34%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y7.76%
ROICexc growth 5Y0.13%
OM growth 3Y2.7%
OM growth 5Y-0.33%
PM growth 3Y-3.94%
PM growth 5Y-4.76%
GM growth 3YN/A
GM growth 5Y-4.8%
F-Score7
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 3.34
Debt/EBITDA 3.19
Cap/Depr 48.94%
Cap/Sales 4.32%
Interest Coverage 3.51
Cash Conversion 120.51%
Profit Quality 229.02%
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 2.36
F-Score7
WACC8.3%
ROIC/WACC1.46
Cap/Depr(3y)43.97%
Cap/Depr(5y)38.02%
Cap/Sales(3y)4.15%
Cap/Sales(5y)3.71%
Profit Quality(3y)130.29%
Profit Quality(5y)142.06%
High Growth Momentum
Growth
EPS 1Y (TTM)9.5%
EPS 3Y15.12%
EPS 5Y9.95%
EPS Q2Q%11.36%
EPS Next Y14.56%
EPS Next 2Y15.53%
EPS Next 3Y16.16%
EPS Next 5Y16.24%
Revenue 1Y (TTM)4.68%
Revenue growth 3Y16.3%
Revenue growth 5Y9.08%
Sales Q2Q%6.01%
Revenue Next Year5.41%
Revenue Next 2Y8.53%
Revenue Next 3Y9.02%
Revenue Next 5Y8.94%
EBIT growth 1Y7.53%
EBIT growth 3Y19.44%
EBIT growth 5Y8.72%
EBIT Next Year30.48%
EBIT Next 3Y17.9%
EBIT Next 5Y16.46%
FCF growth 1Y160.37%
FCF growth 3Y11.78%
FCF growth 5Y18.83%
OCF growth 1Y140.22%
OCF growth 3Y12.58%
OCF growth 5Y18.39%